These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2804664)

  • 21. Toluene and telencephalic dopamine: selective reduction of amine turnover in discrete DA nerve terminal systems of the anterior caudate nucleus by low concentrations of toluene.
    Fuxe K; Andersson K; Nilsen OG; Toftgård R; Eneroth P; Gustafsson JA
    Toxicol Lett; 1982 Jul; 12(2-3):115-23. PubMed ID: 7112606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholecystokinin antagonists inhibit in vivo voltammetric signals generated by KCl-induced slow wave depolarization in rat caudate.
    Wilkerson JW; Kasser RJ; Renner KJ
    Brain Res; 1992 Oct; 594(1):47-55. PubMed ID: 1467941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microinjections of nanogram amounts of sulfated cholecystokinin octapeptide into the rat nucleus accumbens attenuates brain stimulation reward.
    Vaccarino FJ; Koob GF
    Neurosci Lett; 1984 Nov; 52(1-2):61-6. PubMed ID: 6098878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffusion and uptake of dopamine in rat caudate and nucleus accumbens compared using fast cyclic voltammetry.
    Stamford JA; Kruk ZL; Palij P; Millar J
    Brain Res; 1988 May; 448(2):381-5. PubMed ID: 3378163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amphetamine facilitates the in vivo release of neurokinin A in the nucleus accumbens of the rat.
    Lindefors N; Brodin E; Ungerstedt U
    Eur J Pharmacol; 1989 Feb; 160(3):417-20. PubMed ID: 2540996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis.
    Mifsud JC; Hernandez L; Hoebel BG
    Brain Res; 1989 Jan; 478(2):365-7. PubMed ID: 2924134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levels of CCK immunoreactivity and dopamine in the nucleus accumbens after 6-hydroxydopamine lesions of the ventral tegmental area and the nucleus accumbens.
    Igarashi Y; Wiegant VM; Van Ree JM
    Neuropeptides; 1989; 14(2):71-6. PubMed ID: 2812290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of D-2 antagonists on frequency-dependent stimulated dopamine overflow in nucleus accumbens and caudate-putamen.
    May LJ; Wightman RM
    J Neurochem; 1989 Sep; 53(3):898-906. PubMed ID: 2527290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of cholecystokinin release from posterior nucleus accumbens by D-2 dopamine receptor.
    Martin JR; Beinfeld MC; Wang RY
    Brain Res; 1986 Nov; 397(2):253-8. PubMed ID: 2948613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons.
    White FJ; Wang RY
    Brain Res; 1984 May; 300(1):161-6. PubMed ID: 6145498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of long-term haloperidol treatment on the responsiveness of accumbens neurons to cholecystokinin and dopamine: electrophysiological and radioligand binding studies in the rat.
    Debonnel G; Gaudreau P; Quirion R; de Montigny C
    J Neurosci; 1990 Feb; 10(2):469-78. PubMed ID: 2137531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional differences in the regulation of dopamine and noradrenaline release in medial frontal cortex, nucleus accumbens and caudate-putamen: a microdialysis study in the rat.
    Cenci MA; Kalén P; Mandel RJ; Björklund A
    Brain Res; 1992 May; 581(2):217-28. PubMed ID: 1393530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo release of endogenous dopamine from rat caudate putamen and nucleus accumbens by 40 mM potassium chloride.
    Philips SR
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):817-20. PubMed ID: 6686714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrastructural study of cholecystokinin-like immunoreactive nerve terminals in the rat nucleus accumbens.
    Baali-Cherif H; Arluison M; Tramu G
    Neurosci Lett; 1984 Aug; 49(3):331-5. PubMed ID: 6387545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo comparison of the regulation of releasable dopamine in the caudate nucleus and the nucleus accumbens of the rat brain.
    Kuhr WG; Bigelow JC; Wightman RM
    J Neurosci; 1986 Apr; 6(4):974-82. PubMed ID: 3486259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeated administration of high doses of amphetamine increases release of ascorbic acid in caudate but not nucleus accumbens.
    Mueller K
    Brain Res; 1989 Aug; 494(1):30-5. PubMed ID: 2765922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatostatin and cholecystokinin octapeptide differentially modulate the release of [3H]acetylcholine from caudate nucleus but not cerebral cortex: role of dopamine receptor activation.
    Arnerić SP; Reis DJ
    Brain Res; 1986 May; 374(1):153-61. PubMed ID: 2872939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study.
    Ng Cheong Ton JM; Gerhardt GA; Friedemann M; Etgen AM; Rose GM; Sharpless NS; Gardner EL
    Brain Res; 1988 Jun; 451(1-2):59-68. PubMed ID: 2855215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of the releasable pool of CCK in the rat nucleus accumbens and caudate-putamen following lesions of the midbrain.
    Maidment NT; Villafranca NP
    Brain Res; 1997 Feb; 747(2):290-6. PubMed ID: 9046004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons.
    Kelland MD; Zhang J; Chiodo LA; Freeman AS
    Synapse; 1991 Jun; 8(2):137-43. PubMed ID: 1882334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.